Impact of Autumn Budget on Technology & Life Science Startups
With the new government now in office and the 2024 Autumn Budget announcement on 30 October, significant changes are anticipated, especially as the government has emphasized the need to make “difficult decisions”.
In this video, learn how these latest policy changes may affect growth-stage companies in the technology and life sciences sectors across the UK.
About The Speakers:
Malcolm Joy, UK Office Managing Partner
Partner, Frazier & Deeter Advisory, LLC
Jonathan Clark, Partner, Frazier & Deeter Advisory, LLC
Explore related insights
-
Preparing for US Clinical Trials and Market Entry: HIPAA Compliance for UK MedTech
Read more: Preparing for US Clinical Trials and Market Entry: HIPAA Compliance for UK MedTech
-
How NIH Defunding Could Reshape Clinical Trials for UK Medtech Startups
Read more: How NIH Defunding Could Reshape Clinical Trials for UK Medtech Startups
